Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
The primary objective of this trial is to measure changes in physiologic signals to quantify the status of the autonomic nervous system during opioid withdrawal and cravings.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 50
View:
• Participant has a recent history of opioid dependence; prescription or non-prescription
• Participant is currently taking, or plans to initiate, medications for opioid use disorder (MOUD)
• Participant is between 18 and 50 years of age
• Participant is English proficient
• Participant is able to provide informed consent and function at an intellectual level sufficient for study requirements
• Participant is willing to wear wearable sensors for 14 days
Locations
United States
Minnesota
Hazelden Betty Ford Foundation
RECRUITING
Center City
Ohio
Battelle Memorial Institute
ACTIVE_NOT_RECRUITING
Columbus
Contact Information
Primary
Caroline Benner
clinicaltrials@sparkbiomedical.com
(210) 624-8046
Backup
Brooke Le
Time Frame
Start Date: 2025-02-19
Estimated Completion Date: 2027-05-31
Participants
Target number of participants: 20
Treatments
Opioid Use Disorder
Participants with a history of dependence on prescription or non-prescription opioids
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Drug Abuse (NIDA), Battelle Memorial Institute, National Institutes of Health (NIH), The HEAL Initiative, Hazelden Betty Ford Foundation
Leads: Spark Biomedical, Inc.